首页> 外文期刊>癌と化学療法 >A case of postoperative liver metastases from gastric cancer successfully treated with hepatic arterial infusion of paclitaxel
【24h】

A case of postoperative liver metastases from gastric cancer successfully treated with hepatic arterial infusion of paclitaxel

机译:紫杉醇肝动脉灌注成功治疗胃癌术后肝转移1例

获取原文
获取原文并翻译 | 示例
           

摘要

A 69-year-old man underwent total gastrectomy for advanced gastric cancer in August 2001. After surgery, he was treated daily with UFT 300 mg. In October 2002, the tumor marker (CEA) increased in value, and CT revealed multiple liver metastases. Because there were no extrahepatic metastases, we attempted to use hepatic arterial injection chemotherapy. A reservoir was placed in the hepatic artery on November 12. Thereafter, intra-arterial injection of paclitaxel at 120 mg (80 mg/m2) was administered over one hour to the reservoir. This arterial injection chemotherapy was administered once weekly for 3 weeks followed by 1 week rest. After 3 courses, CEA decreased markedly and CT revealed remarkable tumor reduction which was thought to show a partial response (PR). After 6 courses, PR was continued. Adverse effects were only grade 1 alopecia and leukopenia. No major adverse effects were observed. These results suggest that hepatic arterial injection therapy with weekly paclitaxel is effective against recurrent gastric cancer with liver metastases.
机译:一名69岁的男子在2001年8月因胃癌接受了全胃切除术。手术后,他每天接受300 mg UFT的治疗。 2002年10月,肿瘤标志物(CEA)的价值增加,CT显示有多个肝转移。因为没有肝外转移,所以我们尝试使用肝动脉注射化疗。 11月12日,在肝动脉中放置一个储器。此后,在一个小时内向该储器进行动脉内注射120 mg(80 mg / m2)的紫杉醇。每周进行一次动脉注射化疗,持续3周,然后休息1周。 3个疗程后,CEA明显降低,CT显示肿瘤明显减少,这被认为是部分反应(PR)。经过6个课程,继续进行PR。不良反应仅为1级脱发和白细胞减少症。没有观察到重大不良反应。这些结果表明,每周紫杉醇的肝动脉注射疗法可有效治疗复发性胃癌并伴有肝转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号